Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2004 1
2008 1
2010 1
2013 2
2014 2
2016 2
2017 5
2018 1
2019 1
2020 1
2021 7
2022 4
2023 4
2024 5

Text availability

Article attribute

Article type

Publication date

Search Results

31 results

Results by year

Filters applied: . Clear all
Page 1
Patient-Reported Outcomes in OlympiA: A Phase III, Randomized, Placebo-Controlled Trial of Adjuvant Olaparib in gBRCA1/2 Mutations and High-Risk Human Epidermal Growth Factor Receptor 2-Negative Early Breast Cancer.
Ganz PA, Bandos H, Španić T, Friedman S, Müller V, Kuemmel S, Delaloge S, Brain E, Toi M, Yamauchi H, de Dueñas EM, Armstrong A, Im SA, Song CG, Zheng H, Sarosiek T, Sharma P, Geng C, Fu P, Rhiem K, Frauchiger-Heuer H, Wimberger P, t'Kint de Roodenbeke D, Liao N, Goodwin A, Chakiba-Brugère C, Friedlander M, Lee KS, Giacchetti S, Takano T, Henao-Carrasco F, Virani S, Valdes-Albini F, Domchek SM, Bane C, McCarron EC, Mita M, Rossi G, Rastogi P, Fielding A, Gelber RD, Scheepers ED, Cameron D, Garber J, Geyer CE, Tutt ANJ. Ganz PA, et al. Among authors: rossi g. J Clin Oncol. 2024 Apr 10;42(11):1288-1300. doi: 10.1200/JCO.23.01214. Epub 2024 Feb 1. J Clin Oncol. 2024. PMID: 38301187 Clinical Trial.
"Heterogeneity of treatment effect on patients' long-term outcome according to pathological response type in neoadjuvant RCTs for breast cancer.".
Pala L, Sala I, Pagan E, De Pas T, Zattarin E, Catania C, Cocorocchio E, Rossi G, Laszlo D, Ceresoli G, Canzian J, Valenzi E, Bagnardi V, Conforti F. Pala L, et al. Among authors: rossi g. Breast. 2024 Feb;73:103672. doi: 10.1016/j.breast.2024.103672. Epub 2024 Jan 19. Breast. 2024. PMID: 38244459 Free PMC article.
Fine-Tuning Adjuvant Endocrine Therapy for Early-Stage Breast Cancer: An Expert Consensus on Open Issues for Future Research.
Conforti F, Pala L, De Pas T, Zattarin E, Catania C, Cocorocchio E, Rossi G, Laszlo D, Colleoni M, Zambelli A, Hortobagyi GN, Cortes J, Piccart MJ, Dowsett M, Gelber RD, Viale G. Conforti F, et al. Among authors: rossi g. Clin Cancer Res. 2024 Mar 15;30(6):1093-1103. doi: 10.1158/1078-0432.CCR-23-1836. Clin Cancer Res. 2024. PMID: 37906083
Comparing the performance of 2 human papillomavirus assays for a new use indication: a real-world evidence-based evaluation in the United States.
Wheeler CM, Torrez-Martinez NE, Torres-Chavolla E, Parvu V, Andrews JC, Du R, Robertson M, Joste NE, Cuzick J; New Mexico HPV Pap Registry Steering Committee. Wheeler CM, et al. Am J Obstet Gynecol. 2024 Feb;230(2):243.e1-243.e11. doi: 10.1016/j.ajog.2023.09.100. Epub 2023 Oct 6. Am J Obstet Gynecol. 2024. PMID: 37806613 Free article.
Socio-economic outcomes among long-term childhood acute lymphoblastic leukaemia survivors enrolled between 1971 and 1998 in EORTC CLG studies: Results of the 58LAE study.
Barbati M, Kicinski M, Suciu S, Mazingue F, Vandecruys E, Plat G, Uyttebroeck A, Paillard C, Dresse MF, Simon P, Pluchart C, Minckes O, Ferster A, Freycon C, Millot F, Van Der Werff Ten Bosch J, Chantrain C, Paulus R, de Schaetzen G, Rossi G, Rohrlich P, Benoit Y, Piette C; European Organisation for Research and Treatment of Cancer (EORTC) Children's Leukemia Group (CLG). Barbati M, et al. Among authors: rossi g. Eur J Cancer Care (Engl). 2022 Nov;31(6):e13755. doi: 10.1111/ecc.13755. Epub 2022 Oct 25. Eur J Cancer Care (Engl). 2022. PMID: 36284405 Free PMC article.
Organoids: a systematic review of ethical issues.
de Jongh D, Massey EK; VANGUARD consortium; Bunnik EM. de Jongh D, et al. Stem Cell Res Ther. 2022 Jul 23;13(1):337. doi: 10.1186/s13287-022-02950-9. Stem Cell Res Ther. 2022. PMID: 35870991 Free PMC article. Review.
31 results